| 货号:FY12756 | 规格:100 ul | 目录价:¥6488.05 |
产品详情
* 以下信息仅供参考,详情请以原厂网站为准
产品名称:
NSDHL Antibody / NADP dependent steroid dehydrogenase like protein
产品描述:
NSDHL antibody detects NADP dependent steroid dehydrogenase like protein, encoded by the NSDHL gene. This protein is also known as sterol 4 alpha carboxylate 3 dehydrogenase decarboxylating, H105E3, and the human homolog of the mouse bare patches gene. NSDHL is an essential enzyme in the cholesterol biosynthetic pathway. It functions in the endoplasmic reticulum, catalyzing oxidative decarboxylation of C4 methylated sterol intermediates. These steps are necessary for the removal of methyl groups during the conversion of lanosterol to cholesterol. Because cholesterol is critical for membranes, steroid hormones, and signaling lipids, NSDHL plays a central role in both basic metabolism and developmental biology.
NSDHL antibody is widely applied in studies of cholesterol metabolism, embryogenesis, dermatology, and disease research. Mutations in NSDHL cause CHILD syndrome, a rare X linked disorder that results in congenital hemidysplasia, ichthyosiform erythroderma, and limb defects. By detecting NSDHL, researchers can trace how mutations impair cholesterol synthesis and lead to toxic sterol accumulation. The protein is expressed in multiple tissues with high metabolic activity, including liver, brain, and skin, making it a valuable marker for sterol pathway integrity.
Applications of NSDHL antibody include western blotting, immunohistochemistry, and immunofluorescence. Western blot assays identify NSDHL expression in tissue lysates, immunohistochemistry highlights spatial distribution in liver and epidermis, and immunofluorescence reveals its localization in the endoplasmic reticulum. These methods allow researchers to connect protein expression to sterol metabolism and developmental outcomes. Because cholesterol synthesis is fundamental across organisms, NSDHL antibody has relevance in both basic biology and translational studies.
Biochemically, NSDHL functions alongside other C4 demethylation enzymes, including sterol C4 methyl oxidase and 3 beta hydroxysteroid dehydrogenase like proteins. Together they coordinate the removal of C4 methyl groups, ensuring accurate production of downstream sterols. Disruption of NSDHL activity interrupts this sequence, creating intermediates that impair membranes and signal transduction. By applying NSDHL antibody, scientists can evaluate enzyme function within the broader sterol demethylation complex.
Beyond congenital syndromes, NSDHL is increasingly studied in oncology. Cancer cells reprogram metabolism to support proliferation, and cholesterol synthesis is frequently upregulated. NSDHL expression correlates with tumor growth and resistance to certain therapies. Inhibiting sterol biosynthetic enzymes, including NSDHL, is a promising therapeutic strategy under investigation. The antibody therefore has applications in cancer metabolism research, where monitoring NSDHL may reveal vulnerabilities to metabolic intervention.
Cholesterol synthesis also intersects with neurobiology. The brain relies heavily on de novo cholesterol production, and NSDHL mutations or altered expression affect myelination and neuronal function. By detecting NSDHL with antibody based assays, researchers can study sterol metabolism in neurodevelopmental disorders and neurodegeneration. These insights extend to understanding how cholesterol imbalances influence synaptic function and cognition.
NSDHL antibody from NSJ Bioreagents provides strong specificity for detecting this essential sterol dehydrogenase. Its validated performance across molecular and cellular assays ensures accurate measurement of NSDHL in cholesterol metabolism, development, cancer, and neurological research.
NSDHL antibody is widely applied in studies of cholesterol metabolism, embryogenesis, dermatology, and disease research. Mutations in NSDHL cause CHILD syndrome, a rare X linked disorder that results in congenital hemidysplasia, ichthyosiform erythroderma, and limb defects. By detecting NSDHL, researchers can trace how mutations impair cholesterol synthesis and lead to toxic sterol accumulation. The protein is expressed in multiple tissues with high metabolic activity, including liver, brain, and skin, making it a valuable marker for sterol pathway integrity.
Applications of NSDHL antibody include western blotting, immunohistochemistry, and immunofluorescence. Western blot assays identify NSDHL expression in tissue lysates, immunohistochemistry highlights spatial distribution in liver and epidermis, and immunofluorescence reveals its localization in the endoplasmic reticulum. These methods allow researchers to connect protein expression to sterol metabolism and developmental outcomes. Because cholesterol synthesis is fundamental across organisms, NSDHL antibody has relevance in both basic biology and translational studies.
Biochemically, NSDHL functions alongside other C4 demethylation enzymes, including sterol C4 methyl oxidase and 3 beta hydroxysteroid dehydrogenase like proteins. Together they coordinate the removal of C4 methyl groups, ensuring accurate production of downstream sterols. Disruption of NSDHL activity interrupts this sequence, creating intermediates that impair membranes and signal transduction. By applying NSDHL antibody, scientists can evaluate enzyme function within the broader sterol demethylation complex.
Beyond congenital syndromes, NSDHL is increasingly studied in oncology. Cancer cells reprogram metabolism to support proliferation, and cholesterol synthesis is frequently upregulated. NSDHL expression correlates with tumor growth and resistance to certain therapies. Inhibiting sterol biosynthetic enzymes, including NSDHL, is a promising therapeutic strategy under investigation. The antibody therefore has applications in cancer metabolism research, where monitoring NSDHL may reveal vulnerabilities to metabolic intervention.
Cholesterol synthesis also intersects with neurobiology. The brain relies heavily on de novo cholesterol production, and NSDHL mutations or altered expression affect myelination and neuronal function. By detecting NSDHL with antibody based assays, researchers can study sterol metabolism in neurodevelopmental disorders and neurodegeneration. These insights extend to understanding how cholesterol imbalances influence synaptic function and cognition.
NSDHL antibody from NSJ Bioreagents provides strong specificity for detecting this essential sterol dehydrogenase. Its validated performance across molecular and cellular assays ensures accurate measurement of NSDHL in cholesterol metabolism, development, cancer, and neurological research.
反应种属:
Human
宿主来源:
Rabbit
实验应用:
WB, IHC, ICC, IF
同种型:
Rabbit IgG
免疫原:
A synthesized peptide derived from human NSDHL was used as the immunogen for the NSDHL antibody.
克隆性:
Recombinant Rabbit Monoclonal
克隆号:
30N01
纯化方式:
Affinity chromatography
保存温度:
Store the NSDHL antibody at -20oC.
产品形式:
Liquid
存储溶液:
Rabbit IgG in phosphate buffered saline, pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol, 0.4-0.5mg/ml BSA
产地:
美国
上一个:Phospho-PDGF Receptor beta (Tyr1021) Antibody / CD140b
下一个:Phospho-ErbB2 (Tyr1221/Tyr1222) Antibody / HER2 / NEU
您可能感兴趣的产品
4-hydroxy Nonenal Monoclonal Antibody (HNEJ-1/Clone IG10) - HRP Conjugated
货号:45025
ICAM4 antibody [HL5612]
货号:GTX646294
14-3-3 epsilon antibody [HL5606]
货号:GTX646288
Ras (Q61H mutant) antibody [HL5601]
货号:GTX646283
ALDH1L1 antibody [HL5536]
货号:GTX646210
AAV13 Capsid protein VP1 + VP2 + VP3 antibody [HL5535]
货号:GTX646198
ESAM antibody [HL5518]
货号:GTX646181
CD79a antibody [HL5516]
货号:GTX646179
促销活动

官网链接
折扣/货期




复制QQ号成功,请打开QQ后添加好友进行咨询